HUT65731A - Process for preparing methanebisphosphonic acid containing medicaments of fracture healing - Google Patents
Process for preparing methanebisphosphonic acid containing medicaments of fracture healingInfo
- Publication number
- HUT65731A HUT65731A HU9303385A HU9303385A HUT65731A HU T65731 A HUT65731 A HU T65731A HU 9303385 A HU9303385 A HU 9303385A HU 9303385 A HU9303385 A HU 9303385A HU T65731 A HUT65731 A HU T65731A
- Authority
- HU
- Hungary
- Prior art keywords
- preparing
- acid containing
- fracture healing
- containing medicaments
- methanebisphosphonic acid
- Prior art date
Links
- 208000010392 Bone Fractures Diseases 0.000 title 1
- 206010017076 Fracture Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000035876 healing Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- MBKDYNNUVRNNRF-UHFFFAOYSA-N medronic acid Chemical compound OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92810931 | 1992-11-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9303385D0 HU9303385D0 (en) | 1994-03-28 |
| HUT65731A true HUT65731A (en) | 1994-07-28 |
Family
ID=8212039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9303385A HUT65731A (en) | 1992-11-30 | 1993-11-29 | Process for preparing methanebisphosphonic acid containing medicaments of fracture healing |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6255288B1 (hu) |
| JP (1) | JPH06211667A (hu) |
| KR (1) | KR940010998A (hu) |
| AU (1) | AU670337B2 (hu) |
| CA (1) | CA2110110A1 (hu) |
| HU (1) | HUT65731A (hu) |
| IL (1) | IL107764A0 (hu) |
| MX (1) | MX9307479A (hu) |
| NO (1) | NO934317L (hu) |
| NZ (1) | NZ250293A (hu) |
| ZA (1) | ZA938898B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ232599A0 (en) * | 1999-08-19 | 1999-09-09 | Royal Alexandra Hospital For Children, The | Drug for treating fractures |
| NZ523086A (en) * | 2000-06-20 | 2007-07-27 | Novartis Ag | Method of administering bisphosphonates |
| CA2372450A1 (en) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
| CA2497353C (en) * | 2002-09-16 | 2012-08-28 | Novartis Ag | Method for preventing or reducing secondary fractures after hip fracture |
| US8071574B2 (en) * | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
| US20100144679A1 (en) * | 2007-03-21 | 2010-06-10 | Duke University | Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture |
| FR2926081B1 (fr) * | 2008-01-03 | 2010-02-19 | Univ Nantes | Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux |
| EP2473172B1 (en) | 2009-09-01 | 2015-04-08 | Duke University | Bisphosphonate compositions and methods for treating heart failure |
| US9949992B2 (en) | 2011-11-16 | 2018-04-24 | Duke University | Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2531088B1 (fr) | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
| DE3428524A1 (de) | 1984-08-02 | 1986-02-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| DE3770982D1 (de) | 1986-04-24 | 1991-08-01 | Fujisawa Pharmaceutical Co | Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel. |
| DE3623397A1 (de) | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| US5057505A (en) | 1986-11-21 | 1991-10-15 | Ciba-Geigy Corporation | Substituted aminomethanediphosphonic acids and use in medicaments |
| EP0275821B1 (de) | 1986-11-21 | 1992-02-26 | Ciba-Geigy Ag | Neue substituierte Alkandiphosphonsäuren |
| MX21453A (es) | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| MX21452A (es) | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| JPH07502012A (ja) | 1991-05-28 | 1995-03-02 | ザ、プロクター、エンド、ギャンブル、カンパニー | カルシウム、微量ミネラル、ビタミンｄ及び薬物療法剤組合せ |
-
1993
- 1993-11-23 AU AU51874/93A patent/AU670337B2/en not_active Ceased
- 1993-11-26 IL IL10776493A patent/IL107764A0/xx unknown
- 1993-11-26 CA CA002110110A patent/CA2110110A1/en not_active Abandoned
- 1993-11-26 NZ NZ250293A patent/NZ250293A/en unknown
- 1993-11-26 JP JP5296481A patent/JPH06211667A/ja active Pending
- 1993-11-29 HU HU9303385A patent/HUT65731A/hu unknown
- 1993-11-29 NO NO934317A patent/NO934317L/no unknown
- 1993-11-29 ZA ZA938898A patent/ZA938898B/xx unknown
- 1993-11-29 MX MX9307479A patent/MX9307479A/es unknown
- 1993-11-29 US US08/159,096 patent/US6255288B1/en not_active Expired - Lifetime
- 1993-11-30 KR KR1019930025767A patent/KR940010998A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX9307479A (es) | 1994-08-31 |
| CA2110110A1 (en) | 1994-05-31 |
| IL107764A0 (en) | 1994-02-27 |
| AU670337B2 (en) | 1996-07-11 |
| KR940010998A (ko) | 1994-06-20 |
| HU9303385D0 (en) | 1994-03-28 |
| NO934317L (no) | 1994-05-31 |
| US6255288B1 (en) | 2001-07-03 |
| NZ250293A (en) | 1997-06-24 |
| ZA938898B (en) | 1994-06-01 |
| AU5187493A (en) | 1994-06-09 |
| NO934317D0 (no) | 1993-11-29 |
| JPH06211667A (ja) | 1994-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT43825A (en) | Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| HUT45895A (en) | Process for production of serotomin antagonic compounds and medical preparatives containing such compositions | |
| HU903846D0 (en) | Process for producing imidazolyl-alkenic acids and pharmaceutical preparatives containing these compounds as active substance | |
| HUT47561A (en) | Process for production of 3-aryloxi-3-substituated propanamids and medical compositions containing them | |
| HUT50190A (en) | Process for production of n-substituated 1-dezoxinogimiricin and 1-dezoxi-manno-nogimiricin and medical compositions containing them | |
| HUT43583A (en) | Process for production of new 8-alkoxi-quinoline carbonic acid derivatives and medical compounds containing thereof | |
| HUT44941A (en) | Process for producing stabile pharmaceutical compositions containing stimulating factor for colonies of granulocites | |
| HUT50467A (en) | Process for producing 7-/1-azetidinyl/-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid derivatives and pharmaceutical compositions containing them as active components | |
| HUT44787A (en) | Process for production of derivatives of nitrofurane and medical preparatives containing these compounds | |
| HUT48902A (en) | Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
| HUT45982A (en) | Process for production of microlide compositions and medical preparatives containing such compositions | |
| HUT51247A (en) | Process for production of aryl-zyanguananidins and medical compositions containing them | |
| HU9200821D0 (en) | Process for the production of medical preparation containing tioredoxine | |
| HUT46888A (en) | Process for production of 2-acyl-pirrolidin-derivatives and medical preparatives containing such compounds as active substances | |
| HU9303385D0 (en) | Process for preparing methanebisphosphonic acid containing medicaments of fracture healing | |
| HUT53291A (en) | Process for production of medical compositions applicable for treatment of inflammation of diarthrosis | |
| HUT51285A (en) | Process for production of healing nucleosides and medical compositions containing them | |
| HUT46534A (en) | Process for producing pharmaceutical composition containing benzopirane-2-carboxylik acid derivative | |
| HU886797D0 (en) | Process for production of medical compositions against caries of bones | |
| HUT47077A (en) | Process for producing hydrocinnamomic acid derivatives and pharmaceutical compositions containing them as active components | |
| PT86297A (en) | Process for preparing aryloxybenzeneacetic acid derivatives and of pharmaceutical compositions containing the same | |
| HUT48885A (en) | Process for producing nukleotid-analogues and pharmaceutical compositions containing them as active components | |
| HUT47591A (en) | Process for production of nucleozides with healing effect and medical compositions containing them | |
| HUT52517A (en) | Process for producing antiseptic nukleozides and pharmaceutical compositions containing them | |
| HUT45397A (en) | Process for production of dosable percutane medical compositions containing nicorandile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DGB9 | Succession in title of applicant |
Owner name: NOVARTIS AG., CH |
|
| DFC4 | Cancellation of temporary protection due to refusal |